“Are patents and antitrust liability mutually exclusive?” This was the underlying question posed by Marc Brotman, Pfizer, David Rodi, Baker Botts, and Willard Tom, FTC, during the Antitrust workshop at the LES Spring Meeting. The panel engaged in a high level discussion of the tension between patent and antitrust law, focusing on the FTC’s Antitrust Guidelines for the Licensing of Intellectual Property, and recent legal issues. An antitrust law primer was provided Seminar Date:
June 14, 2011
|
Online Materials LES Member Price:$0.00 Non-Member Price:$0.00 |